[CYCC] YoY Quarter Result on 30-Sep-2017 [#Q3]

Stock
[CYCC] Cyclacel Pharmaceuticals, Inc.
Announcement Date
13-Nov-2017
Financial Year
2017
Quarter
30-Sep-2017 [#Q3]
Profit Trend
QoQ- 15.09%
YoY- 36.97%
Quarter Report
CYCC's Result
CYCC's Financial Summary
View:
Show?
Quarter Result
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
Revenue 0 0 0 0 205 715 735 -
PBT -2,537 -2,174 -2,369 -2,076 -3,400 -3,187 -5,661 -12.51%
Tax -281 -273 -301 -219 -454 -478 -750 -15.08%
NP -2,256 -1,901 -2,068 -1,857 -2,946 -2,709 -4,907 -12.13%
Tax Rate - - - - - - - -
Total Cost 2,256 1,901 2,068 1,857 3,151 3,424 5,642 -14.15%
Ratio Analysis
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
NP Margin 0.00 0.00 0.00 0.00 -1,437.07 -378.88 -667.62 -
Per Share
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
EPS -0.46 -2.21 -3.45 -3.78 -16.96 -18.75 -51.93 -54.48%
EPS Diluted -0.46 -2.21 -3.45 -3.78 -16.96 -18.75 -51.93 -54.48%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.